| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $180.0M | +16.3% |
| Cost of Revenue | $22.1M | +9.0% |
| Gross Profit | $158.0M | +17.4% |
| R&D Expense | $64.1M | +10.9% |
| SG&A Expense | $42.7M | +27.8% |
| Operating Income | -$84.5M | -22.0% |
| Interest Expense | $43K | -57.4% |
| Pre-tax Income | -$78.8M | -16.9% |
| Income Tax | $1.4M | +30.5% |
| Net Income | -$80.2M | -17.1% |
| EPS (Basic) | -$1.70 | -11.1% |
| EPS (Diluted) | -$1.70 | -11.1% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $41.4M | +2.2% |
| Short-term Investments | $112.3M | -12.2% |
| Accounts Receivable | $44.8M | +12.6% |
| Current Assets | $224.3M | -2.3% |
| Total Assets | $247.8M | -2.1% |
| Current Liabilities | $112.5M | +18.5% |
| Total Liabilities | $117.3M | +14.2% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$26.9M | +34.7% |
| Capital Expenditures | $4.7M | -16.6% |
| Investing Cash Flow | $15.4M | +166.0% |
| Financing Cash Flow | $12.9M | +33.2% |
| Free Cash Flow | -$31.6M | +32.5% |
| Stockholders' Equity |
| $130.4M |
| -13.2% |